Cargando…
OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma
Over 80% of high-grade gliomas have alterations in members of the p53 pathway, a central regulator of cell cycle progression and apoptosis that becomes activated in response to cellular stress and DNA damage. For tumors that retain wild-type p53, pathway deregulation frequently occurs through the am...
Autores principales: | Rendo, Veronica, Lupien, Leslie, Khuu, Nicholas, Pelton, Kristine, Lu, Sophie, Khadka, Prasidda, Langhnoja, Jaldeep, Phoenix, Timothy, Ligon, Keith, Bandopadhayay, Pratiti, Beroukhim, Rameen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255430/ http://dx.doi.org/10.1093/noajnl/vdab070.031 |
Ejemplares similares
-
DIPG-54. p53 pathway reactivation as a therapeutic strategy in diffuse intrinsic pontine glioma
por: Lupien, Leslie, et al.
Publicado: (2022) -
LGG-45. Genetic dependencies inMYB/MYBL1-driven pediatric low-grade glioma models
por: Condurat, Alexandra-Larisa, et al.
Publicado: (2022) -
RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
por: Khadka, Prasidda, et al.
Publicado: (2020) -
OMRT-7. Angiogenesis inhibitors strongly synergize with therapeutics targeting tumor metabolism
por: Khadka, Sunada
Publicado: (2021) -
DIPG-22. DISSECTING THE ONCOGENIC ROLE OF FOXR2 IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Tsai, Jessica W, et al.
Publicado: (2020)